Industries
Every US-listed company grouped by sector and industry. Drill from sectors into industry groups and individual industries to compare returns, breadth and momentum.
Tiles are sized by market cap and coloured by return over the chosen period. Click a group or tile to drill in; click a company for its quote. Search for a company to see where it sits.
Industries in Health Care
| Industry | Companies | Market cap | 1D | Median stock | Up today | > 50-day | > 200-day | 52-wk hi / lo | RSI |
|---|---|---|---|---|---|---|---|---|---|
| Drugs283 | 318 | $5.75T | +2.47% | −0.51% | 40% | 21% | 40% | 4 / 31 | 37 |
| Measuring, Analyzing, and Controlling Instruments; Photographic, Medical and Optical Goods; Watches and Clocks38 | 88 | $1.09T | +0.02% | −0.43% | 34% | 25% | 48% | 1 / 2 | 47 |
| Hospital and Medical Service Plans6324 | 10 | $617B | +3.23% | +1.11% | 70% | 80% | 80% | 1 / 0 | 63 |
| Health Services80 | 59 | $442B | +0.95% | +0.70% | 61% | 58% | 77% | 1 / 0 | 56 |
| Drugs, Drug Proprietaries, and Druggists' Sundries5122 | 4 | $232B | +2.03% | +1.69% | 75% | 100% | 100% | 0 / 0 | 71 |
| Commercial Physical and Biological Research8731 | 8 | $112B | +1.27% | +1.06% | 75% | 63% | 100% | 0 / 0 | 50 |
Return follows the weighting above. Up today, above the 50- and 200-day averages: share of companies. 52-week: companies at a new 52-week high / low today.
Largest companies in Health Care
100 of 487| Symbol | Name | Market cap | 1D | 1M | YTD | 1Y | RSI | > 50-day | > 200-day | 52-wk |
|---|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co. | $1.04T | +3.62% | +6.39% | +12.47% | +47.52% | 60 | ✓ | ✓ | |
| JNJ | Johnson & Johnson | $599B | +2.13% | −4.97% | +22.69% | +33.01% | 41 | ✓ | ||
| ABBV | Abbvie Inc. | $485B | +3.32% | +7.77% | +24.07% | +23.09% | 70 | ✓ | ✓ | High |
| MRK | Merck & Co., Inc. | $350B | +3.80% | +2.49% | +40.01% | +71.96% | 55 | ✓ | ✓ | |
| UNH | UNITEDHEALTH GROUP INCORPORATED (Delaware) | $339B | +4.73% | +5.24% | +19.84% | +10.31% | 62 | ✓ | ✓ | |
| NVS | Novartis AG | $271B | +3.14% | +5.96% | +6.54% | +13.75% | 56 | |||
| AZN | AstraZeneca PLC | $242B | +3.99% | +0.11% | +76.25% | +91.73% | 51 | ✓ | ||
| AMGN | Amgen Inc | $223B | +3.21% | +13.43% | +30.19% | +45.73% | 60 | ✓ | ✓ | |
| GILD | Gilead Sciences Inc | $183B | +3.80% | +4.95% | +25.09% | +29.89% | 61 | ✓ | ✓ | |
| ABT | Abbott Laboratories | $178B | +0.35% | +0.92% | −17.81% | −21.62% | 54 | |||
| NVO | Novo-Nordisk A/S | $168B | +0.16% | −10.37% | −25.08% | −33.70% | 36 | |||
| PFE | Pfizer Inc. | $162B | +2.96% | +6.03% | +17.31% | +18.12% | 66 | ✓ | ✓ | High |
| ISRG | Intuitive Surgical Inc. | $149B | −0.43% | +11.42% | −25.80% | −3.55% | 62 | ✓ | ||
| VRTX | Vertex Pharmaceuticals Inc | $123B | +2.74% | −3.13% | +9.96% | +22.37% | 42 | ✓ | ||
| MDT | Medtronic plc | $119B | +1.31% | +0.51% | −1.91% | −1.41% | 64 | ✓ | ✓ | |
| BMY | Bristol-Myers Squibb Co. | $116B | +4.61% | −6.98% | +9.90% | +36.15% | 42 | |||
| MCK | McKesson Corporation | $112B | +1.53% | +8.56% | +19.05% | +26.91% | 71 | ✓ | ✓ | |
| SYK | Stryker Corporation | $108B | −0.33% | +0.04% | −19.87% | −22.83% | 47 | |||
| HCA | HCA Healthcare, Inc. | $99.8B | +2.10% | +11.00% | +0.77% | +14.55% | 74 | ✓ | ✓ | |
| SNY | Sanofi | $93.7B | +1.66% | −6.20% | −17.93% | −18.50% | 37 | |||
| GSK | GSK plc | $92.7B | +3.46% | −4.28% | −2.39% | +9.57% | 47 | |||
| ELV | Elevance Health, Inc. | $92.2B | +0.66% | +2.53% | +22.12% | +21.82% | 67 | ✓ | ✓ | |
| MRNA | Moderna, Inc. | $86.3B | +4.65% | +57.40% | +667.38% | +746.30% | 69 | ✓ | ✓ | |
| MMM | 3M Company | $83.9B | +1.04% | −0.13% | +2.72% | +8.84% | 48 | ✓ | ||
| REGN | Regeneron Pharmaceuticals Inc | $77.5B | +3.35% | +0.55% | +0.84% | +39.56% | 54 | ✓ | ||
| CI | The Cigna Group | $74.7B | +2.50% | +0.24% | +5.21% | −1.97% | 64 | ✓ | ✓ | |
| COR | Cencora, Inc. | $63.0B | +1.84% | +3.98% | −0.47% | +6.05% | 68 | ✓ | ✓ | |
| BSX | Boston Scientific Corp. | $62.8B | −0.72% | −1.98% | −54.90% | −54.71% | 44 | |||
| TAK | Takeda Pharmaceutical Company Limited | $59.2B | +2.65% | +1.66% | +21.94% | +38.56% | 61 | ✓ | ✓ | |
| NTRA | Natera, Inc. | $57.0B | −0.23% | +12.53% | +72.31% | +126.65% | 58 | ✓ | ✓ | |
| CAH | Cardinal Health, Inc. | $55.5B | +3.35% | +6.49% | +20.55% | +60.55% | 70 | ✓ | ✓ | |
| BDX | Becton, Dickinson and Co. | $51.0B | +0.81% | +1.60% | −2.67% | +1.19% | 62 | ✓ | ✓ | |
| HUM | Humana Inc. | $50.5B | +1.67% | +7.76% | +66.87% | +57.71% | 62 | ✓ | ✓ | |
| ARGX | argenx SE | $50.5B | +1.95% | −16.48% | −2.69% | +2.34% | 29 | |||
| EW | Edwards Lifesciences Corp | $49.1B | +1.38% | +0.83% | +1.41% | +18.51% | 49 | ✓ | ||
| TEVA | Teva Pharmaceutical Industries Limited | $48.1B | −1.28% | +3.75% | +30.47% | +103.40% | 61 | ✓ | ✓ | |
| IQV | IQVIA Holdings Inc. | $42.9B | +0.51% | −2.84% | +16.24% | +28.58% | 51 | ✓ | ✓ | |
| IDXX | Idexx Laboratories Inc | $41.0B | +1.67% | +3.58% | −21.81% | −16.47% | 53 | |||
| RVMD | Revolution Medicines, Inc. | $40.4B | +2.70% | −5.54% | +142.96% | +296.96% | 45 | ✓ | ||
| ONC | BeOne Medicines Ltd. | $39.5B | +0.69% | +1.44% | +15.69% | +7.48% | 46 | ✓ | ||
| CNC | Centene Corporation | $34.0B | +1.89% | +3.69% | +70.50% | +92.96% | 68 | ✓ | ✓ | High |
| BIIB | Biogen Inc. | $33.8B | +1.72% | +7.71% | +32.30% | +60.92% | 64 | ✓ | ✓ | |
| RMD | ResMed Inc. | $33.1B | +0.11% | +2.55% | −2.32% | −13.82% | 67 | ✓ | ✓ | |
| DXCM | DexCom, Inc. | $32.1B | −1.87% | −3.45% | +25.76% | +28.02% | 41 | ✓ | ||
| MDLN | Medline Inc. | $31.3B | +0.64% | +11.90% | −14.45% | — | 57 | ✓ | ||
| GEHC | GE HealthCare Technologies Inc. | $31.1B | −0.47% | +6.87% | −16.52% | −4.69% | 59 | |||
| ZTS | Zoetis Inc. | $30.7B | +1.33% | +2.53% | −40.16% | −47.08% | 59 | ✓ | ||
| ALC | Alcon Inc. | $30.5B | +1.38% | −5.74% | −18.96% | −12.02% | 41 | |||
| ALNY | Alnylam Pharmaceuticals, Inc. | $29.9B | +0.29% | −5.79% | −43.55% | −51.72% | 40 | |||
| WST | West Pharmaceutical Services, Inc. | $26.2B | +0.76% | +2.64% | +36.17% | +42.74% | 59 | ✓ | ✓ | |
| DGX | Quest Diagnostics Inc. | $25.4B | +1.29% | −5.52% | +34.52% | +27.71% | 49 | ✓ | ||
| LH | Labcorp Holdings Inc. | $25.4B | +1.18% | −2.05% | +26.49% | +14.71% | 54 | ✓ | ||
| RPRX | Royalty Pharma plc | $25.2B | +4.28% | +0.89% | +52.67% | +66.45% | 55 | ✓ | ||
| PHG | Koninklijke Philips N.V. | $24.3B | +0.44% | +0.40% | −4.25% | −5.72% | 53 | |||
| ROIV | Roivant Sciences Ltd. | $24.1B | +0.81% | −14.89% | +54.93% | +107.40% | 37 | ✓ | ||
| UTHR | United Therapeutics Corp | $23.3B | −0.62% | +7.93% | +10.83% | +22.72% | 56 | ✓ | ✓ | |
| GMAB | Genmab A/S | $22.5B | +0.88% | +8.02% | +19.77% | +12.88% | 59 | ✓ | ✓ | |
| BNTX | BioNTech SE | $22.4B | −0.39% | −8.30% | −6.87% | −13.33% | 35 | |||
| INCY | Incyte Genomics Inc | $22.0B | +2.72% | −8.35% | +12.96% | +31.68% | 35 | ✓ | ||
| GH | Guardant Health, Inc. | $21.8B | +0.56% | −7.21% | +59.58% | +164.04% | 43 | ✓ | ||
| THC | Tenet Healthcare Corporation | $21.5B | +1.76% | +4.12% | +36.67% | +42.95% | 63 | ✓ | ✓ | |
| STE | STERIS plc | $21.2B | −0.23% | +3.32% | −14.30% | −7.74% | 56 | |||
| INSM | Insmed, Inc. | $21.1B | +1.03% | −18.45% | −43.81% | −40.35% | 29 | |||
| VTRS | Viatris Inc. | $19.8B | +1.10% | +4.74% | +40.08% | +76.88% | 53 | ✓ | ✓ | |
| ZBH | Zimmer Biomet Holdings, Inc. | $17.6B | −0.34% | −6.75% | +2.06% | −3.49% | 49 | ✓ | ||
| MEDP | Medpace Holdings, Inc. | $17.0B | +1.11% | −0.62% | +9.79% | +16.92% | 54 | ✓ | ✓ | |
| EXEL | Exelixis Inc | $14.7B | +2.49% | +7.19% | +39.15% | +58.66% | 66 | ✓ | ✓ | |
| SOLV | Solventum Corporation | $14.7B | +1.11% | −3.11% | +10.12% | +23.11% | 48 | ✓ | ||
| ASND | Ascendis Pharma A/S Ordinary Share | $14.7B | +1.70% | −5.33% | +6.45% | +8.91% | 43 | |||
| CRL | Charles River Laboratories International, Inc. | $14.3B | +1.00% | +10.67% | +51.39% | +76.98% | 59 | ✓ | ✓ | |
| NBIX | Neurocrine Biosciences Inc | $13.7B | +0.58% | −9.41% | −4.17% | −1.05% | 34 | |||
| JAZZ | Jazz Pharmaceuticals, Inc. | $13.7B | −0.35% | −12.95% | +23.32% | +55.14% | 22 | |||
| BAX | Baxter International Inc. | $12.9B | −0.36% | +4.60% | +29.77% | +12.17% | 57 | ✓ | ||
| CORT | Corcept Therapeutics Inc. | $12.7B | −1.33% | +4.88% | +233.99% | +62.49% | 50 | ✓ | ✓ | |
| ICLR | Icon Plc | $12.7B | +2.82% | −2.02% | −7.27% | −9.18% | 53 | ✓ | ✓ | |
| PEN | Penumbra, Inc. | $12.6B | +0.03% | +0.53% | +2.96% | +26.44% | 54 | |||
| HALO | Halozyme Therapeutics, Inc. | $12.4B | +6.57% | +9.95% | +73.58% | +78.82% | 64 | ✓ | ✓ | High |
| BTSG | BrightSpring Health Services, Inc. | $12.4B | +1.12% | +7.66% | +69.16% | +114.89% | 61 | ✓ | ✓ | |
| SMMT | Summit Therapeutics Inc. | $12.4B | −2.51% | −13.05% | −13.49% | −34.02% | 41 | |||
| BBIO | BridgeBio Pharma, Inc. | $12.4B | +2.59% | −5.04% | −15.10% | +16.05% | 38 | |||
| EHC | Encompass Health Corporation | $12.3B | +1.79% | +3.74% | +19.24% | +4.33% | 63 | ✓ | ✓ | |
| SNN | Smith & Nephew plc | $11.7B | +0.07% | −0.46% | −15.03% | −20.82% | 55 | |||
| DVA | DaVita Inc. | $11.6B | −0.76% | −5.34% | +59.05% | +45.83% | 49 | ✓ | ✓ | |
| TECH | Bio-Techne Corp. | $11.4B | +0.03% | +0.22% | +23.28% | +21.54% | 56 | ✓ | ✓ | |
| FMS | Fresenius Medical Care AG | $11.2B | +2.18% | −6.18% | −9.57% | −21.42% | 43 | |||
| ELAN | Elanco Animal Health Incorporated | $11.2B | +0.62% | −1.96% | −0.35% | +12.52% | 47 | |||
| RGEN | Repligen Corp | $11.1B | +1.58% | +1.99% | +8.75% | +19.86% | 51 | ✓ | ✓ | |
| MOH | Molina Healthcare, Inc. | $10.9B | −0.15% | +1.06% | +20.54% | +7.68% | 63 | ✓ | ✓ | |
| RDY | Dr. Reddy's Laboratories Limited | $10.6B | −0.16% | +10.39% | −9.19% | −11.21% | 59 | ✓ | ||
| UHS | Universal Health Services, Inc. | $10.6B | +3.84% | +5.11% | −14.74% | −6.00% | 67 | ✓ | ✓ | |
| BMRN | BioMarin Pharmaceuticals Inc | $10.5B | +1.40% | −14.45% | −7.22% | +5.13% | 30 | |||
| PCVX | Vaxcyte, Inc. | $10.5B | +1.12% | +14.09% | +46.40% | +54.19% | 58 | ✓ | ✓ | |
| MDGL | Madrigal Pharmaceuticals, Inc. | $10.4B | +1.75% | −12.09% | −21.01% | +7.55% | 28 | |||
| OSCR | Oscar Health, Inc. | $10.4B | +1.57% | +5.80% | +138.83% | +68.24% | 65 | ✓ | ✓ | |
| IBRX | ImmunityBio, Inc. | $10.4B | +1.12% | +21.74% | +400.51% | +299.60% | 59 | ✓ | ✓ | |
| COO | The Cooper Companies, Inc. | $10.4B | +0.53% | +3.02% | −33.04% | −20.81% | 36 | |||
| GMED | Globus Medical Inc | $10.2B | −0.01% | +2.17% | −12.60% | +32.74% | 51 | |||
| ALGN | Align Technology Inc | $10.2B | +0.63% | −1.74% | −7.50% | +11.50% | 45 | |||
| ENSG | The Ensign Group, Inc. | $10.1B | +1.49% | +1.79% | +0.95% | −0.66% | 55 | ✓ | ||
| TWST | Twist Bioscience Corporation | $10.0B | −2.09% | +7.28% | +367.09% | +391.57% | 45 | ✓ | ✓ |
How the industry explorer works
Industries. Each company is placed by the Standard Industrial Classification (SIC) code it reports in its SEC filings, then grouped into one of 11 sectors. SIC has three levels below the sector: major groups (two digits, e.g. 28 Chemicals), industry groups (three digits, e.g. 283 Drugs) and industries (four digits, e.g. 2834 Pharmaceutical Preparations). Codes ending in 0 or 00 mean a company is classified at the group level only; those appear as "(general)". Groups with a single sub-group are merged so every drill step shows a choice.
Cap-weighted vs median. The cap-weighted return is how the group performed as a basket, so the largest companies dominate it. The median stock shows what a typical member did. A wide gap between the two means a few giants are carrying, or dragging, the group.
Companies, not tickers. A company with several share classes (Alphabet, Berkshire) counts once, through its most traded class. Blank-check companies (SPACs) are left out. Use the size filter to drop micro-caps, which dominate the counts in industries like biotech.
Find a company. Search by ticker or name to jump to the industry a company is classified in. It stays marked on the map and its path stays above the figures while you move between levels, so you can see which sector, group and industry it belongs to and how it ranks there. Funds and ETFs have no industry and are not on the map.
Figures are price returns (excluding dividends) as of the latest close, refreshed each trading day after the market closes. The S&P 500 comparison uses SPY over the same period.